Evaluation and Management of Recurrent Severe Periumbilical Colicky Pain in a 65-Year-Old Male on Quetiapine
This patient requires immediate contrast-enhanced CT imaging during an episode of pain to exclude life-threatening quetiapine-induced intestinal ischemia or necrosis, followed by urgent surgical consultation if any concerning features are identified.
Critical Drug-Induced Etiology
Quetiapine carries a significant risk of anticholinergic-induced gastrointestinal complications, including intestinal ischemia and necrosis, which can be rapidly fatal. 1, 2 The French Pharmacovigilance database documented 38 cases of ischemic colitis and gastrointestinal necrosis associated with antipsychotics, with a mortality rate of 36.8% despite surgical intervention. 2 Quetiapine specifically has been implicated in fatal cases of intestinal necrosis, particularly when combined with other anticholinergic agents. 1, 3
Key Clinical Features of Antipsychotic-Induced Intestinal Complications:
- Recurrent colicky periumbilical pain is the hallmark presenting symptom and should never be dismissed as benign in patients on quetiapine 1, 4
- Initial imaging may be falsely reassuring because ischemia can be intermittent or early in its course 5, 6
- Rapid progression to necrosis, perforation, and septic shock can occur within hours to days despite initially mild symptoms 1, 2
- The average age of affected patients is 42.7 years, but elderly patients are at higher risk due to reduced physiologic reserve 2
Immediate Diagnostic Approach
Obtain Contrast-Enhanced CT During Pain Episode
The single most important diagnostic step is obtaining an abdominal CT scan with intravenous contrast during an episode of severe pain. 5, 6 Non-contrast CT has limited sensitivity (48-50%) for detecting early or low-grade obstruction and cannot adequately assess bowel wall perfusion. 6
Specific imaging findings that mandate emergent surgical consultation include: 5, 6
- Bowel wall thickening with abnormal enhancement pattern
- Mesenteric edema or fat stranding
- Pneumatosis intestinalis (gas within bowel wall)
- Portal venous gas
- Closed-loop configuration
- Transition point with proximal bowel dilation
- Free intraperitoneal air
Alternative Imaging if Contrast Contraindicated
If the patient has severe renal impairment or true contrast allergy:
- MR enterography provides detailed contrast-free evaluation and can detect subtle ischemic changes 6
- Point-of-care ultrasound offers 90% sensitivity for small bowel obstruction and can identify transition points, though it is operator-dependent 6
Exclude Mechanical Obstruction
Even with normal initial imaging, intermittent mechanical obstruction from adhesions must be excluded in this clinical scenario. 5, 6
Clinical Features Suggesting Mechanical Obstruction:
- Symptoms that reliably worsen after solid food intake 6
- Visible peristalsis on abdominal examination (in thin patients) 5, 6
- History of prior abdominal surgery (85% sensitivity for adhesive obstruction) 6
- Loud bowel sounds during pain episodes 5
- Relief with liquid or low-residue diet 5
A transition point between dilated and normal-caliber bowel on imaging confirms mechanical obstruction, but this may not be visible if the obstruction has resolved or if the bowel is fixed by adhesions. 5
Management Algorithm
If Imaging Reveals High-Risk Features:
- Immediate surgical consultation 5, 6
- Discontinue quetiapine and all anticholinergic medications immediately 1, 2
- Nil-by-mouth status with intravenous crystalloid resuscitation 6
- Nasogastric decompression if obstruction present 6
- Broad-spectrum antibiotics if perforation or ischemia suspected 1, 2
If Initial Imaging is Normal but Symptoms Persist:
- Discontinue quetiapine immediately given the life-threatening risk of progression 1, 2
- Coordinate with psychiatry to transition to an antipsychotic with minimal anticholinergic effects (e.g., aripiprazole, ziprasidone, or first-generation agents like loxapine) 1
- Obtain repeat contrast-enhanced CT during the next pain episode 5, 6
- Consider water-soluble contrast study (using non-iodinated agents if contrast allergy) to differentiate complete from partial obstruction 6
- Serial clinical monitoring for development of peritonitis, fever, or hemodynamic instability 1, 2
Critical Pitfalls to Avoid
Do not continue quetiapine while pursuing a diagnostic workup. The mortality rate from antipsychotic-induced intestinal necrosis is 36.8%, and progression can be rapid despite initially mild symptoms. 2 Six patients in the French database died despite surgical intervention, and 13 recovered with permanent sequelae. 2
Do not assume functional pain or irritable bowel syndrome in a patient on quetiapine with recurrent severe colicky pain. 5, 6 The anticholinergic effects of quetiapine decrease intestinal peristalsis, and without prompt recognition and management, this can progress to colonic ischemia or necrosis. 1, 2
Do not add opioid analgesics for pain control, as they will worsen intestinal dysmotility and can precipitate narcotic bowel syndrome, further complicating the clinical picture. 5
Do not rely on laboratory markers alone. Leukocytosis may be absent early in the course, and metabolic acidosis is a late finding indicating advanced ischemia. 1, 4
Examine all hernia orifices systematically, especially the femoral canal, as missed hernias can cause intermittent obstruction with high strangulation risk. 6
Monitoring After Quetiapine Discontinuation
If quetiapine is discontinued and symptoms resolve:
- Do not rechallenge with quetiapine or structurally similar antipsychotics (olanzapine, clozapine), as cross-reactivity for gastrointestinal complications has been documented 1, 7, 3
- Coordinate closely with psychiatry to select an alternative antipsychotic with minimal anticholinergic burden 1
- Counsel the patient and caregivers about the need for immediate medical evaluation if abdominal pain recurs 2